Imiquimod
- Generic Name
- Imiquimod
- Brand Names
- Aldara, Vyloma, Zyclara
- Drug Type
- Small Molecule
- Chemical Formula
- C14H16N4
- CAS Number
- 99011-02-6
- Unique Ingredient Identifier
- P1QW714R7M
- Background
Imiquimod is an immune response modifier that acts as a toll-like receptor 7 agonist. Imiquimod is commonly used topically to treat warts on the skin of the genital and anal areas. Imiquimod does not cure warts, and new warts may appear during treatment. Imiquimod does not fight the viruses that cause warts directly, however, it does help to relieve and cont...
- Indication
For the topical treatment of clinically typical, nonhyperkeratotic, nonhypertrophic actinic keratoses on the face or scalp in immunocompetent adults. Also indicated for the treatment of external genital and perianal warts/condyloma acuminata in individuals 12 years old and above.
- Associated Conditions
- Actinic Keratoses of the face, Actinic Keratoses of the scalp, Condylomata Acuminata, Herpes Simplex Infections, Molluscum Contagiosum, Superficial Basal Cell Carcinoma
- Associated Therapies
- -
Topical Imiquimod Compared With Surgery in Treating Patients With Basal Cell Skin Cancer
- Conditions
- First Posted Date
- 2003-08-07
- Last Posted Date
- 2013-09-17
- Lead Sponsor
- Queen's Medical Center
- Target Recruit Count
- 500
- Registration Number
- NCT00066872
- Locations
- 🇬🇧
Chesterfield Royal Hospital, Chesterfield, England, United Kingdom
🇬🇧Solihull Hospital, Solihull, England, United Kingdom
🇬🇧Queen's Medical Centre, Nottingham, England, United Kingdom
Imiquimod in Preventing Cervical Cancer in Women With Cervical Neoplasia
- Conditions
- Interventions
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2016-07-13
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 57
- Registration Number
- NCT00031759
- Locations
- 🇺🇸
CCOP - Sioux Community Cancer Consortium, Sioux Falls, South Dakota, United States
🇺🇸Mayo Clinic, Jacksonville, Florida, United States
🇺🇸CCOP - Carle Cancer Center, Urbana, Illinois, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.